1mPossible Initiative

Abstract:

This paper explores Argentina’s potential to become a global hub in the emerging longevity and rejuvenation industry. It presents the 1mPossible Initiative as a case study of international cooperation, connecting leading scientists, biotech innovators, and policymakers from the United States, Europe, India, and Latin America. The paper outlines strategic opportunities for Argentina to align its foreign policy, regulatory frameworks, and scientific ecosystem with global trends in healthy aging. Expert contributions provide a multidimensional view of longevity science as a catalyst for economic growth and geopolitical relevance. The paper positions Argentina as an emerging strategic actor in the global longevity and healthy aging landscape.

Introduction: Argentina in the Race for Longevity

The world is facing a revolution in the field of longevity and rejuvenation. Across the globe, major powers recognize longevity science as a strategic driver of health systems transformation, economic productivity, and technological leadership. Leading nations such as the United States, China, and Israel are already heavily investing in technologies to extend life and improve its quality. Living longer and healthier lives is increasingly feasible, requiring coordinated scientific, regulatory, and policy-oriented initiatives. However, Argentina has not yet defined a strategy to insert itself into this new world and its emerging future economy.

In this context, the private sector has begun to play a coordinating role through internationally driven scientific and strategic initiatives. One such effort is the 1mPossible Initiative, designed to foster international coordination and strategic alignment in the longevity field.

Argentina has the potential to assume a leadership role in the global longevity industry. It has an outstanding scientific ecosystem, as well as the capacity, experience, and medical resources to position itself as a key player in the world’s new advances in the longevity and rejuvenation industry.
Longevity is no longer science fiction; it is a tangible, multi-billion-dollar global economy.

This paper explores how Argentina can position itself as a key player in this revolution, with the collaboration and support of the most important scientists and figures in this field from the United States, Switzerland, Germany, and India.
We are witnessing the birth of a new global economy, and Argentina has a historic opportunity to position itself in time.
Longevity is no longer science fiction or just research, it is an emerging industry comparable to AI ten years ago.

1. The 1mPossible Initiative: A Platform for Global Coordination

The 1mPossible Initiative is a global project aimed at accelerating research in longevity and rejuvenation through international and local cooperation in science, technology, and policy. It is supported by scientists, biotech companies, and innovation centers from countries such as Switzerland, Germany, the United States, and India, as well as from Argentina's main technology hubs. The 1mPossible Initiative acts as a bridge between researchers, investors, and public policy makers.

Its impact is already becoming evident in the acceleration of key research, the growing interest of investment funds in startups in the sector, and the strengthening of the national biotech ecosystem. Through strategic alliances, Argentina not only actively participates in this global network but also has the opportunity to consolidate itself as the Latin American hub for the longevity economy.

Key aspects of the initiative include:

• Serving as a link between the scientific community, private capital, and public policy design.
• Facilitating coordination between stakeholders in Argentina and leading figures in the United States, Europe, India, and Switzerland.
• Promoting the development of active research lines, increasingly attracting the attention of specialized investors.
• Providing a results-oriented platform with a collaborative and multidisciplinary approach.

Since its launch, the initiative has received positive feedback and expressions of interest from international biotech institutions and academic leaders, reflecting its alignment with emerging trends in health policy, technology, and aging.

2. The Science of Longevity: Opportunities and Challenges
At the international level, longevity has ceased to be merely a field of research and has become an industry with enormous economic potential. Cooperation between countries has proven to be key in accelerating progress and generating new therapies against aging.

In this context, Argentina has scientific talent, access to biotechnology, and a growing ecosystem. This positions the country as a potential longevity hub in Latin America. From this position, strong international collaboration is being promoted. However, Argentina still faces regulatory and investment challenges that must be addressed in order to fully seize these opportunities.

3. Strategies for Argentina: Policy and International Cooperation
To establish itself in the longevity industry, Argentina must adopt concrete strategies, such as:
• Creating a regulatory framework that facilitates research on longevity therapies
• Promoting collaborations with international centers in the United States, India and Europe
• Encouraging investment in biotech startups specializing in aging
• Developing AI-based programs focused on preventive healthcare

The 1mPossible Initiative seeks to connect Argentina with the global community in this field, fostering an international cooperation ecosystem for the development of innovative solutions in longevity.

Argentina stands out for its highly qualified human and scientific capital, as well as for internationally recognized experts in artificial intelligence. In the field of biotechnology, revolutionary projects are being developed with the potential to generate a global impact in the medium term.

The opportunities for the world through unified collaboration are unique. Locally, Argentina has native animal species of high biological value and highly competitive operational costs. Regulatory reforms allow Argentina to move faster than the United States or Europe in terms of bureaucratic processes. Based on this, a more innovation-friendly regulatory system must be created, with processes similar to those of the FDA, but executed in a fraction of the time.

It is not enough for Argentina to merely participate; the country is well positioned to propose a strategic roadmap for Latin America. Argentina can play a role in the longevity sector comparable to that of countries that successfully positioned themselves as global technology hubs during early stages of industry consolidation.

4. Global Perspectives and Strategic Expert Contributions
This paper includes contributions from internationally recognized experts in human aging, artificial intelligence, biotechnology, and health policy. Their insights provide a global and multidisciplinary perspective that strengthens the analysis and aligns the initiative with the most relevant international advances. Their achievements and professional backgrounds are detailed at the end of the article.

We sincerely thank all contributors for sharing their expertise, which adds scientific legitimacy and reinforces the importance of a global vision for addressing longevity challenges from emerging regions.

Steve Horvath
Pioneer in epigenetics and creator of the "epigenetic aging clock" (USA)

"Global cooperation in longevity research accelerates innovation by pooling diverse expertise, resources, and data, enabling breakthroughs that no single nation could achieve alone. For Argentina, collaborating with countries like the USA, Europe, and the UK could amplify its role in this field, fostering knowledge exchange and opening doors for local scientists. Likewise, other nations benefit from Argentina’s unique perspectives, access to species, growing biotech talent, and potential for cost-effective research, enriching the global longevity ecosystem.”

Ezequiel Conti
Physicist and technologist. Former National Space Agency engineer (Argentina)

“Optimizing systems under extreme conditions is a challenge that transcends disciplines and borders. In space exploration, we design technology capable of withstanding the passage of time in hostile environments. The 1mPossible initiative applies this same philosophy to longevity: understanding biological limits and developing solutions to overcome them. Engineering, physics, and biotechnology converge in a global effort to redefine how we preserve life and extend human health.”

Emil Kendzorra
CEO of Tomorrow Biostasis, a leading European company in human cryopreservation and biostasis (Switzerland)
"At Tomorrow Biostasis, we believe that global collaboration is key to advancing longevity research. Establishing strong connections between Argentina, Switzerland, and Germany opens new pathways for scientific progress. Through the 1mPossible Initiative, we support Argentina’s efforts in this field, fostering innovation and building a bridge for knowledge exchange between regions with shared ambitions."

Global Longevity Federation
India-based international organization promoting research, collaboration, and education in healthy aging and life extensión (India)

"Global collaboration is key to advancing longevity science, as it enables the exchange of research, technology, and best practices across borders. By fostering international partnerships, we can accelerate breakthroughs, develop inclusive policy frameworks, and ensure equitable access to longevity innovations. A united approach strengthens the global longevity ecosystem, benefiting societies worldwide. The Global Longevity Federation recognizes the vital role of international cooperation in advancing longevity science. As a global initiative representing India, we are committed to fostering meaningful collaborations with Argentina and beyond to drive innovation, knowledge exchange, and sustainable solutions for healthy aging worldwide. We look forward to strengthening connections between India and Argentina in this field."

Glenn Heller II
Top 100 consultant in longevity, Investor with focus on public policy (USA)
"Longevity isn’t just a concern for one country, it’s a human challenge we must tackle together as a united front since aging knows no borders! The time is ripe for Argentina to get involved, as the demand for solutions to age-related challenges continues to rise worldwide. I think if we can make longevity more profitable, we can help accelerate funding and speed up global research. Longevity is no longer a taboo topic but rather the next trillion-dollar industry. By embracing a global perspective, we can unlock a wider range of possibilities where I even envision a future where we might give rise to a new breed of enhanced humans thanks to things such as CRISPR."

Kenneth Scott
Distinguished mathematician and leader of the Human Longevity Syndicate (USA)
"Global collaboration is essential to advancing longevity research, particularly in overcoming regulatory barriers that impede timely clinical trials. In many countries, including the United States, bureaucratic processes delay the initiation of human trials, leading to prolonged suffering and mortality from age-related diseases. For instance, cardiovascular disease claims approximately 600,000 lives annually in the U.S., yet stringent regulations hinder expedited testing of potential therapies on at-risk individuals. Argentina's recent governmental reforms aimed at streamlining healthcare regulations present a unique opportunity to lead in the implementation of longevity therapies. By fostering international partnerships and adopting efficient regulatory frameworks, Argentina can accelerate the delivery of life-extending treatments, benefiting both its citizens and the global community.​"

Gabriel Cian

President of 2060 Foundation, a U.S.-based organization promoting global investment in longevity (USA)

"At the ‘2060 Foundation’, we champion a global paradigm shift in healthcare and longevity science. Human longevity is the greatest investment opportunity in history, and for the first time, defeating aging is no longer a distant dream—it is an ambitious yet achievable goal. We stand at a critical inflection point, where longevity will soon experience its ‘ChatGPT moment’—a tipping point that will spark widespread investment, much like AI today. Aging is humanity’s universal challenge, transcending borders and social divisions. With recent scientific breakthroughs and the power of AI, we have the opportunity to redefine human life on Earth—if we act together as a global force. Our mission is to help Argentina, along with all other countries, participate in this revolution."

Dylan V. Livingston
President of A4LI, the leading organization shaping longevity-focused public policy in the United States (USA)

"Like the Human Genome Project and many other major scientific endeavors throughout history, longevity science requires international cooperation. With the Trump and Milei administrations bringing the U.S. and Argentina closer together, now is the ideal moment to collaborate in advancing longevity research. As fertility rates in both Argentina (among the lowest in South America) and the United States decline, and the average age in both countries rises, innovation in longevity science becomes increasingly urgent. The Alliance for Longevity Initiatives (A4LI), a political advocacy nonprofit based in Washington, D.C., is taking concrete steps to accelerate access to longevity therapeutics, which will help alleviate the pressures of aging demographic structures. We look forward to working closely with A4LI and other key stakeholders in the U.S. longevity ecosystem to strengthen international ties and drive meaningful progress. We support the 1mPossible Initiative and express our willingness to collaborate in promoting international integration in the longevity field."

Chris Meniw
Recognized leader in education, space, and emerging technologies in Latin America.(Argentina)

"International collaboration in longevity science can be revolutionized by artificial intelligence (AI) and senolysis, optimizing the understanding of aging and mitigation of age-related diseases. This could mark a historic turning point in global health."

Daniela López De Luise
Global leader in machine learning and AI applied to healthcare innovation (Argentina)

“Since the beginnings of medical science, humans have sought to support a better quality of life through healthcare. Over time, measures to cure diseases and ailments shifted toward a preventive approach. Today, thanks to Intelligent Systems, we can envision a predictive model, and thus avoid illnesses and other age-related conditions. Recent advancements and support technologies are no longer based solely on the data provided; they are capable of reconstructing what is not received and even going further to complete what is yet to come, with acceptable and beneficial certainty.
To adapt is to survive. Natural intelligence has proven this throughout evolution. Today, this adaptation involves understanding systems with highly sophisticated behaviors.
These systems, along with artificial intelligence, are already redefining medicine and biotechnology, and the 1mPossible initiative is at the forefront of this convergence. Argentina’s collaboration in an international framework that seeks to enhance these technologies is a necessity, and it is an honor to be part of an initiative that is paving the way toward this transformation.”

Elizabet Schlundt
Attorney at Law. Legal and Governance Coordination (Argentina)
“Legal certainty is the cornerstone that enables this innovation to continue on its path of growth, providing specialized support and guidance across different areas.
Strategic planning and negotiation at both national and international levels will allow us to build cooperative partnerships, while also developing solid legal frameworks of an international nature, ensuring that all stakeholders who join the Initiative can operate with the confidence and security necessary for collaboration and long-term sustainability of this unprecedented endeavor.”

These contributions reflect the international relevance of the 1mPossible Initiative and its capacity to foster a global network of scientific and strategic cooperation, positioning Argentina as a strategic actor in longevity science.

5. A Global Science for a Global Challenge
Longevity science knows no borders. Its advances imply a profound transformation in public health, the economy, and the ethics of the 21st century. What once seemed like a marginal field of research now represents a new structural axis for the societies of the future.
Countries that understand this shift and act cooperatively will be better positioned to shape the next industrial transformation centered on extended and healthy life.
In this context, Argentina faces a strategic opportunity. Not only because of its scientific capabilities or human capital, but due to its strategic role as a bridge between the Northern and Southern Hemispheres, between innovation hubs and emerging regions.

From the 1mPossible Initiative, we propose that this transformation should happen through international alliances, evidence-based public policies, and an ecosystem where science, ethics, and purpose move forward together. It is no longer just about living longer, but about preserving life in all its forms.

6. Conclusion: The Time is Now
The experts have made it clear: the time to act is now. Longevity is not the future, it is the present. International cooperation is already underway. Science is advancing.
What remains essential is political and institutional determination.
Argentina can choose between being a consumer of technologies developed elsewhere or becoming a key player in a new era of global health. With initiatives such as the 1mPossible Initiative and the support of international leaders, concrete pathways are being developed for Argentina to become an active and central participant in this process.
Figures like Steve Horvath, Emil Kendzorra, Glenn Heller and other leading scientists highlight the importance of an international integration strategy. They all agree on one key point: global collaboration is not optional, it is essential.
Change will not come only from laboratories but also from parliaments, businesses and collective decisions.
Some observers have suggested that these efforts are ahead of their time. In reality, the current moment is precisely when coordinated action is needed.

Longevity is not just about living longer, it is about living better. And Argentina can be part of the story that changes the course of human aging.

Authors and Contributors

• Sebastián Cippitelli (Argentina) – Chief Scientific Strategist & Founder of the 1mPossible Initiative. Member of the Argentine Council for International Relations (CARI).
• Steve Horvath (USA) – Leading scientist in epigenetics and longevity. Creator of the epigenetic clock. Former professor at UCLA.

• Ezequiel Conti (Argentina) Physicist and Technologist. Former software lead at the Argentine National Space Agency (CONAE), with experience in satellite systems and extreme environment technology.
• Emil Kendzorra (Switzerland) – CEO of Tomorrow Biostasis, a pioneering European organization offering cryopreservation services and promoting biostasis as a path to life extension.
• Global Longevity Federation (India) – International alliance advancing education, policy, and innovation in healthy aging and longevity.

• Glenn Heller II (USA) –Top 100 Longevity Consultant. Investor and researcher in aging, with a focus on CRISPR and public policy.

• Kenneth Scott (USA) – Distinguished Mathematician & Biohacker | Board Member at leading biotech firms | Leader of the Human Longevity Syndicate.
• Gabriel Cian (USA) – President of the 2060 Foundation, whose purpose is to help Humanity Defeat Aging by 2060.
• Dylan V. Livingston (USA) – Founder and CEO of the Alliance for Longevity Initiatives (A4LI). Leading advocate for legislation aimed at extending healthy lifespan in the United States, with direct engagement with members of Congress on aging-related policy.

• Chris Meniw (Argentina) – Top 10 Tech Speakers in Latin America, CEO of Space Space Kids Foundation, Co-Founder & CEO of Humanversum Academy.
• Daniela Lopez De Luise (Argentina) –Ph.D. in Computer Science. Former President of IEEE Argentina. Leading global figure in machine learning, artificial intelligence and computational intelligence.

Legal and Governance Coordination

• Elizabet Schlundt (Argentina) Attorney; Legal and Governance Coordination.

About the Coordination and Contributions

Concept and scientific coordination by Sebastián Cippitelli, who guided the overall vision and integrated contributions from global experts. He authored the introduction and the conclusion, ensuring a unified message on the importance of international cooperation in longevity science and life preservation.

Global Collaboration in Longevity Science. Argentina’s Role as an Emerging Country and the 1mPossible Initiative: A Global Perspective

A Policy & Strategy White Paper on Global Collaboration in Longevity Science

Initiative Coordination & Strategic Framework

Sebastián Cippitelli (Argentina)
Founder and Scientific Coordinator, 1mPossible Initiative

Member of the Argentine Council for International Relations (CARI)